CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Visterra, Inc.

For profitWebsite ↗

Also known as: Visterra, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Mar 13, 2025

Acquired by Otsuka on Sep 4, 2018

Timeline

2000s

Jan 1, 2007
Visterra, Inc.— Founded

2010s

Sep 4, 2018
Otsuka— Acquired By

Drugs by trial phase (5 distinct, 9 trials)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (11)

NCT06937593Lead sponsorPhase 1Mar 13, 2025
NCT06212804Lead sponsorPhase 1Nov 22, 2023
NCT05418101Lead sponsorPhase 1Apr 28, 2022
NCT05418101Overall official - principal investigatorPhase 1Apr 28, 2022
NCT04287985Lead sponsorPhase 2Mar 1, 2020
NCT03719443Lead sponsorPhase 1Oct 23, 2018
NCT03040141Lead sponsorPhase 2Jun 1, 2017
NCT02989194Lead sponsorPhase 2Dec 1, 2016
NCT02989194Study directorPhase 2Dec 1, 2016
NCT02468115Lead sponsorPhase 2May 1, 2015
NCT02045472Lead sponsorPhase 1Sep 1, 2014

Details

Founded: Boston, MA, US Jan 1, 2007
Last known activity: Mar 13, 2025